NOV 03, 2016 12:00 PM PDT

Point of Care Testing - Why Knowing Now Matters in the Emergency Department

1 229

  • Director, Scientific Affairs, Alere, Inc., Adjunct Assoc Professor of Pathology, Mount Sinai School of Medicine
      Dr. Jacobs received his B.S. degree in Chemistry and Natural Sciences from Muhlenberg College in Allentown, PA and then obtained a Ph.D. in Biochemistry from the University of South Carolina. He did postdoctoral training in Clinical Chemistry & Toxicology at the University of North Carolina, Chapel Hill. Dr. Jacobs was a laboratory director at The Mount Sinai Hospital, Bellevue Medical Center and Henry J Carter and Coler-Goldwater Specialty Hospitals for over 25 years and has extensive experience with POCT, critical care testing, laboratory consolidation and automation, computerization and automatic result reporting, and planning and performance of clinical trials for various main laboratory and POCT systems. He has over 60 peer reviewed publications and textbook chapters and was the principal investigator on several beta site studies for various POCT analytical systems.

      Dr. Jacobs has been involved in establishing clinical diagnostic regulatory and accreditation standards at the local, national and international levels. He is a former director of the New York State laboratory accreditation program and is active in the Clinical and Laboratory Standards Institute. He is Chair of the CLSI Expert Panel on Point of Care Testing and was a member of the development committees for EP18 and EP23. Additionally, Dr. Jacobs is a past member, and current observer, of the US Technical Advisory Group for ISO Technical Committee 212 on Clinical Laboratory Testing and In Vitro Diagnostic Test Systems.

      Dr. Jacobs was the AACC Liaison to the Connectivity Industrial Consortium for POC Testing and was secretary & chair of both ANSA and the Point-of-Care Testing Division. He was a member of the NACB LMPG on Point of Care Testing Committee and is active in the International Federation of Clinical Chemistry. He is past chair of the Communications & Publications Division, was on several IFCC committees and working groups.


    There have been significant increases in emergency room visits across the US and delays in the ED leads to poor outcomes.  There is an association between waiting times and short term mortality and hospital admission.  Laboratory turnaround time can impact ED operations and, based on simulation modeling, the best performance is predicted when the TAT is 40 minutes or less.   The needs of every ED are different and this presentation will look at the impact of Point of Care testing on the provision of medical care and ED operations in three clinical conditions: chest pain (cardiac), sepsis (critical care) and infectious diseases.   

    Learning Objectives:

    • Understand the association between ED waiting times and short term mortality and hospital admissions.
    • Describe the operational benefits that can be achieved with a rapid chest pain disposition protocol.
    • Understand the role of lactate in the identification and monitoring of sepsis.
    • Explain the impact on key ED operational metrics of rapid infectious disease testing.

    Show Resources
    Loading Comments...